Company Filing History:
Years Active: 2016
Title: Helga Eveline De Vries: Innovator in Blood-Brain Barrier Research
Introduction
Helga Eveline De Vries is a prominent inventor based in Amsterdam, Netherlands. She has made significant contributions to the field of biomedical research, particularly in understanding the blood-brain barrier and its implications for various neurological conditions.
Latest Patents
Helga holds a patent related to miRNAs involved in blood-brain barrier function. This invention focuses on the use of specific nucleic acids to modulate the blood-brain barrier, either by increasing or decreasing its function. The patent addresses the treatment of conditions such as multiple sclerosis, HIV infection, Alzheimer's disease, Parkinson's disease, and epilepsy. Additionally, it includes an assay for identifying drugs that can effectively modulate blood-brain barrier function.
Career Highlights
Helga is affiliated with the Vereniging voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek en Patiëntenzorg, where she conducts her research. Her work has garnered attention for its potential to impact therapeutic strategies for serious neurological disorders.
Collaborations
Helga collaborates with Arie Reijerkerk, contributing to advancements in their shared field of research.
Conclusion
Helga Eveline De Vries is a key figure in the study of blood-brain barrier function, with her innovative patent paving the way for new treatment options for various neurological diseases. Her contributions continue to influence the landscape of biomedical research.